Close Menu
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Ye Mahaveer Ka Panth Hai, Har Prani Me Sant Hai’ – Mahavir Nirvana Katha resonates at Bharat Mandapam

November 16, 2026

Unihealth Hospitals Limited Reports H1 FY27 Revenue of Rs 76.45 Crore; Positive Operating Cash Flow of Rs 23.83 Crore Amidst Significant Expansion Investments

November 16, 2026

Chhattisgarh CM Inaugurates PanIIT Alumni India’s Nursing Skill College Initiative in Jashpur

November 16, 2026
Facebook X (Twitter) Instagram
Trending
  • Ye Mahaveer Ka Panth Hai, Har Prani Me Sant Hai’ – Mahavir Nirvana Katha resonates at Bharat Mandapam
  • Unihealth Hospitals Limited Reports H1 FY27 Revenue of Rs 76.45 Crore; Positive Operating Cash Flow of Rs 23.83 Crore Amidst Significant Expansion Investments
  • Chhattisgarh CM Inaugurates PanIIT Alumni India’s Nursing Skill College Initiative in Jashpur
  • 8th International HKL Conference Begins at Gurdwara Bulandpuri Sahib; Flags of 116 Nations Hoisted to Promote Global Unity
  • Cash Ur Drive Marketing Reports Strong H1 FY27 Performance: EBITDA Rising 13% and Net Profit Growing 8% YoY
  • Shyam Dhani Industries Limited Reports H1 FY27 Financial Performance
  • Apollo Health strengthens its expansion in North India with New Clinic and National Reference Laboratory in Gurugram
  • Batman x Samsonite: Iconic DC Super Hero, Reimagined Through the Lens of Modern Travel
The Startup StoryThe Startup Story
  • Business
  • Lifestyle
  • National
  • Education
  • Health
  • Technology
  • World
The Startup StoryThe Startup Story
Home»National»Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India
National

Optimus Announces Interim Clinical Results from Phase III Clinical Trials of Molnupiravir Conducted in India

By July 21, 2021No Comments
Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Share
Facebook Twitter LinkedIn Pinterest Email

Hyderabad (Telangana) [India], July 21: Optimus Pharma on Sunday submitted the interim result of Phase III Clinical Trials for orally administered Molnupiravir capsules on patients with Mild Covid-19 patients. With an acute shortage of antiviral drugs in the market against the SARS-CoV-2 infection, it is imperative that more drugs with potent antiviral activity against SARS-CoV-2 be introduced.

In a statement, the MD and Chairman Dr. D Srinivasa Reddy had declared that Optimus pharma has internally developed the active pharmaceutical ingredient (API) and the formulations for the product and had obtained approval for conducting Phase 3 Clinical Trial.

As per the clinical trial protocol approved, 1218 subjects with mild COVID-19 will be randomised in the study in a 1:1 ratio to Molnupiravir with the standard of care, or standard of care alone. The treatment duration is a maximum of 05 days and the total study duration will be a maximum of 28 days from randomisation.

“Optimus is all geared to immediately begin manufacturing of Molnupiravir for COVID-19 patients in India. The interim results on 353 patients have shown promising results of Molnupiravir. The drug has been successful in reducing viral load effectively with RT-PCR negativity achieved 78.3 % in the test arm compared to 48.4% in the standard of care arm on Day 5. Day 10 and Day 14 of the treatment duration have also given excellent results wherein the remaining patients have successfully achieved RT-PCR negativity. The trial has also revealed clinical improvement in a significantly high proportion of patient’s health. The safety of the drug has also been established with no observed side effects, co-morbidity, or morbidity observed during and after the treatment duration,” Chairman & Managing Director – Dr. D Srinivasa Reddy said.

Optimus has approached the Drugs Controller General of India (DCGI) to seek Emergency Use Authorization for Molnupiravir in India.

Optimus Pharma is committed to serve the nation and fight back the pandemic to restore normalcy in the lives of people affected by COVID-19 at the earliest. With the cooperation of the government and our stakeholders, and a special thanks to the Subject Expert Committee of the CDSCO for their valuable contribution and their recommendations to the project, we hope to deliver the product in India by leveraging our solid distribution strength across the country.

national
Share. Facebook Twitter Pinterest LinkedIn Tumblr Telegram Email

Related Posts

World Diabetes Day: Making Smarter Snacking Choices with American Pistachios

November 16, 2026

SOUHARDYA 2026 Inaugurated at RGIPT Jais, Promoting Social Innovation, Sustainability and Entrepreneurship

November 2, 2026

India’s CNAP caller-name display goes live on 4G and 5G networks from November 1

October 31, 2026

Comments are closed.

Top Posts

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020

Final Battle – Avengers: Infinity War – Youtube

February 22, 2020
Don't Miss
Lifestyle

Ye Mahaveer Ka Panth Hai, Har Prani Me Sant Hai’ – Mahavir Nirvana Katha resonates at Bharat Mandapam

By Arjun SinghNovember 16, 2026

Musical Katha by Rajiv Jain CA brings alive saga of Pawapuri, message of Ahimsa from…

Unihealth Hospitals Limited Reports H1 FY27 Revenue of Rs 76.45 Crore; Positive Operating Cash Flow of Rs 23.83 Crore Amidst Significant Expansion Investments

November 16, 2026

Chhattisgarh CM Inaugurates PanIIT Alumni India’s Nursing Skill College Initiative in Jashpur

November 16, 2026

8th International HKL Conference Begins at Gurdwara Bulandpuri Sahib; Flags of 116 Nations Hoisted to Promote Global Unity

November 16, 2026
Most Popular

Can we guess, how much she is happy?

February 22, 2020

When sunrise and the day begins.

February 22, 2020

Make your own inhouse library and learn

February 22, 2020
Categories
  • Business
  • Business News
  • Education
  • Entertainment
  • Finance
  • Health
  • Lifestyle
  • National
  • Press Release
  • Sports
  • Technology
  • Uncategorized
  • World
Our Picks

Ye Mahaveer Ka Panth Hai, Har Prani Me Sant Hai’ – Mahavir Nirvana Katha resonates at Bharat Mandapam

November 16, 2026

Unihealth Hospitals Limited Reports H1 FY27 Revenue of Rs 76.45 Crore; Positive Operating Cash Flow of Rs 23.83 Crore Amidst Significant Expansion Investments

November 16, 2026

Chhattisgarh CM Inaugurates PanIIT Alumni India’s Nursing Skill College Initiative in Jashpur

November 16, 2026

Type above and press Enter to search. Press Esc to cancel.